Survival of HIV-1 in Syringes
- 1 January 1999
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 20 (1) , 73-80
- https://doi.org/10.1097/00042560-199901010-00011
Abstract
We performed a study to determine the duration of survival of HIV-1 in syringes typically used by injectors of illicit drugs (IDUs). We describe the effectiveness of a microculture assay in detecting viable virus in volumes of blood typical of those commonly found inside used syringes. Using this assay and modeling the worsecase situation for syringe sharing, we have recovered viable, proliferating HIV-1 from syringes that have been maintained at room temperature for periods in excess of 4 weeks. The percentage of syringes with viable virus varied with the volume of residual blood and the titer of HIV-1 in the blood. These experiments provide a scientific basis for needle exchange schemes, harm reduction, and other interventions among IDUs that support the nonsharing and removal of used syringes from circulation.Keywords
This publication has 21 references indexed in Scilit:
- Syringe Use and Reuse: Effects of Syringe Exchange Programs in Four CitiesJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needlesPublished by American Medical Association (AMA) ,1997
- A method for evaluating needle exchange programmesStatistics in Medicine, 1994
- Infectious Decay of Human Immunodeficiency Virus Type 1 in PlasmaThe Journal of Infectious Diseases, 1993
- The limitations of the concept of needle sharingAIDS, 1990
- Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug UsersNew England Journal of Medicine, 1989
- Needlestick and Needleshare- The DifferenceThe Journal of Infectious Diseases, 1989
- The Survival of Human Immunodeficiency Virus in Water, Sewage and Sea WaterWater Science & Technology, 1989
- Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.American Journal of Public Health, 1987
- Stability and inactivation of HTLV-III/LAV under clinical and laboratory environmentsJAMA, 1986